SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001193125-24-113987
Filing Date
2024-04-25
Accepted
2024-04-25 16:29:35
Documents
11

Document Format Files

Seq Description Document Type Size
1 S-1/A d827405ds1a.htm S-1/A 430527
2 EX-1.1 d827405dex11.htm EX-1.1 40028
3 EX-4.11 d827405dex411.htm EX-4.11 81516
4 EX-4.12 d827405dex412.htm EX-4.12 73402
5 EX-4.13 d827405dex413.htm EX-4.13 80648
6 EX-5.1 d827405dex51.htm EX-5.1 18519
7 EX-10.19 d827405dex1019.htm EX-10.19 190859
8 EX-23.1 d827405dex231.htm EX-23.1 2004
9 GRAPHIC g827405g0425044022580.jpg GRAPHIC 4025
10 GRAPHIC g827405g25u10.jpg GRAPHIC 2934
11 GRAPHIC g827405g85a01.jpg GRAPHIC 47299
  Complete submission text file 0001193125-24-113987.txt   993709
Mailing Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339
Business Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339 678-392-3419
Inhibikase Therapeutics, Inc. (Filer) CIK: 0001750149 (see all company filings)

IRS No.: 263407249 | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-278844 | Film No.: 24876822
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)